NET vs. VRNA
NET (Cloudflare, Inc.) and VRNA (Verona Pharma plc) are both stocks. NET operates in Software - Infrastructure (Technology), while VRNA operates in Biotechnology (Healthcare). At a 0.17 correlation, their price movements are largely independent.
Performance
NET vs. VRNA - Performance Comparison
Loading charts...
Returns By Period
NET
- 1D
- 3.16%
- 1M
- 19.31%
- YTD
- 19.56%
- 6M
- 19.83%
- 1Y
- 37.06%
- 3Y*
- 51.62%
- 5Y*
- 19.99%
- 10Y*
- —
VRNA
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NET vs. VRNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NET Cloudflare, Inc. | 19.56% | 83.09% | 29.33% | 84.16% | -65.62% | 73.05% | 345.43% | -5.22% |
VRNA Verona Pharma plc | 0.00% | 130.21% | 133.60% | -23.92% | 288.84% | -4.00% | 21.74% | 27.78% |
Correlation
The correlation between NET and VRNA is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019 | 0.17 |
The correlation between NET and VRNA shifts across timeframes, from 0.04 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NET:
$83.12B
VRNA:
$9.72B
NET:
-$0.25
VRNA:
-$0.69
NET:
35.27
VRNA:
57.97
NET:
54.44
VRNA:
34.92
NET:
$2.33B
VRNA:
$167.65M
NET:
$1.71B
VRNA:
$159.52M
NET:
$168.53M
VRNA:
-$40.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NET vs. VRNA — Risk / Return Rank
NET
VRNA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
NET vs. VRNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cloudflare, Inc. (NET) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NET | VRNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.16 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.01 | — | — |
| Martin ratioReturn relative to average drawdown | 2.17 | — | — |
Loading charts...
Drawdowns
NET vs. VRNA - Drawdown Comparison
Loading charts...
Drawdown Indicators
| NET | VRNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.58% | — | — |
Max Drawdown (1Y)Largest decline over 1 year | -36.76% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -45.00% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -82.58% | — | — |
Current DrawdownCurrent decline from peak | -13.55% | — | — |
Average DrawdownAverage peak-to-trough decline | -37.50% | — | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.11% | — | — |
Volatility
NET vs. VRNA - Volatility Comparison
Loading charts...
Volatility by Period
| NET | VRNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.92% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 53.98% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 60.15% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.54% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.76% | — | — |
Dividends
NET vs. VRNA - Dividend Comparison
Neither NET nor VRNA has paid dividends to shareholders.
Financials
NET vs. VRNA - Financials Comparison
This section allows you to compare key financial metrics between Cloudflare, Inc. and Verona Pharma plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NET vs. VRNA - Profitability Comparison
NET - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cloudflare, Inc. reported a gross profit of 455.60M and revenue of 639.76M. Therefore, the gross margin over that period was 71.2%.
VRNA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.
NET - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cloudflare, Inc. reported an operating income of -61.99M and revenue of 639.76M, resulting in an operating margin of -9.7%.
VRNA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.
NET - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cloudflare, Inc. reported a net income of -22.93M and revenue of 639.76M, resulting in a net margin of -3.6%.
VRNA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.
Frequently Asked Questions
NET and VRNA have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NET and VRNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer